Literature DB >> 15089805

Drug metabolism and ageing.

M T Kinirons1, M S O'Mahony.   

Abstract

Important changes in drug metabolism occur with ageing. Age-associated reductions in function of some but not all cytochrome P450 enzymes (CYPs) have been described. Induction and inhibition of CYPs needs to be revisited in light of recent advances. The function and pharmacology of transporters have not yet been examined for an age-related effect. Finally, the concept of frailty is being underpinned by studies documenting a decline in drug metabolism and changes in disposition in frail older people compared with either healthy elderly or the young.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15089805      PMCID: PMC1884487          DOI: 10.1111/j.1365-2125.2004.02096.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  46 in total

1.  Interaction of citrus juices with felodipine and nifedipine.

Authors:  D G Bailey; J D Spence; C Munoz; J M Arnold
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

2.  Effects of aging and liver disease on disposition of lorazepam.

Authors:  J W Kraus; P V Desmond; J P Marshall; R F Johnson; S Schenker; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

3.  Plasma aspirin esterase: the influence of old age and frailty.

Authors:  F M Williams; H Wynne; K W Woodhouse; M D Rawlins
Journal:  Age Ageing       Date:  1989-01       Impact factor: 10.668

4.  Nutrition and oxidative drug metabolism in man: relative influence of dietary lipids, carbohydrate, and protein.

Authors:  K E Anderson; A H Conney; A Kappas
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

5.  Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.

Authors:  R B Kim; B Leake; M Cvetkovic; M M Roden; J Nadeau; A Walubo; G R Wilkinson
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

6.  The association of age with aspirin esterase activity in human liver.

Authors:  C Yelland; J Summerbell; E Nicholson; B Herd; H Wynne; K W Woodhouse
Journal:  Age Ageing       Date:  1991-01       Impact factor: 10.668

7.  The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women.

Authors:  K Groen; M A Horan; N A Roberts; R S Gulati; B Miljkovic; E J Jansen; V Paramsothy; D D Breimer; C F van Bezooijen
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

Review 8.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

9.  The association of age and frailty with paracetamol conjugation in man.

Authors:  H A Wynne; L H Cope; B Herd; M D Rawlins; O F James; K W Woodhouse
Journal:  Age Ageing       Date:  1990-11       Impact factor: 10.668

10.  Debrisoquine hydroxylation phenotyping in geriatric psychopharmacology.

Authors:  B G Pollock; J M Perel; L P Altieri; M Kirshner; A L Fasiczka; P R Houck; C F Reynolds
Journal:  Psychopharmacol Bull       Date:  1992
View more
  57 in total

1.  Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.

Authors:  Mona Darwish; Mary Kirby; Edward T Hellriegel; Ronghua Yang; Philmore Robertson
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

Review 2.  Age-Related Changes in Hepatic Function: An Update on Implications for Drug Therapy.

Authors:  Joseph L Tan; Jacques G Eastment; Arjun Poudel; Ruth E Hubbard
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

Review 3.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Pharmacological perspectives on the detoxification of plant secondary metabolites: implications for ingestive behavior of herbivores.

Authors:  Stuart McLean; Alan J Duncan
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

Review 5.  Do we learn the right things from clinical trials?

Authors:  Silvio Garattini; Vittorio Bertele'
Journal:  Eur J Clin Pharmacol       Date:  2008-01-29       Impact factor: 2.953

Review 6.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

7.  Summary of the 2017 Alcohol and Immunology Research Interest Group (AIRIG) meeting.

Authors:  Holly J Hulsebus; Brenda J Curtis; Patricia E Molina; Majid Afshar; Lisbeth A Boule; Niya Morris; Ali Keshavarzian; Jay K Kolls; Samantha M Yeligar; Michael E Price; Todd A Wyatt; Mashkoor A Choudhry; Elizabeth J Kovacs
Journal:  Alcohol       Date:  2017-10-31       Impact factor: 2.405

Review 8.  Treatment of Glioblastoma in the Elderly.

Authors:  Rebecca A Harrison; John F de Groot
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

Review 9.  Kidney transplantation in the elderly.

Authors:  Edmund Huang; Dorry L Segev; Hamid Rabb
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

10.  Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors.

Authors:  Nael Al Koudsi; Ewa B Hoffmann; Abbas Assadzadeh; Rachel F Tyndale
Journal:  Eur J Clin Pharmacol       Date:  2009-12-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.